StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SURGY.IS$66.80-1.04%
Fair $66.80+0.0%

SURGY.IS

SURGY.IS

Real Estate / Real Estate - DevelopmentIstanbul

$66.80

-0.70 (-1.04%)

Fairly Valued+0.0%Fair Value $66.80Fund rank 23/100 · Data gapFallback financials|
SA 22/D
F-Score: 2/9

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 43.0/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 28/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

22/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific NAV/AFFO model required: REIT/real-estate targets are disabled until FFO/AFFO/NAV/cap-rate data exists. REIT NAV/AFFO valuation requires positive AFFO/share history or TTM AFFO/share; generic FCF remains disabled.
Thesis & Journal · SURGY.ISLocal privado en este navegador · SURGY.IS
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$11.2B

P/E

11.8x

↑

EV/EBITDA

N/A

•

ROE

10.8%

↑

Gross Margin

N/A

•

Debt/Equity

N/A

•
52-Week Range$67
$40$88

TradingView lightweight chart

SURGY.IS price, volumen y niveles de valoración

Último $66.80Periodo +57.9%
Fair value: $66.80

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

—

FCF CAGR

—

FCF margin

—

FCF / Net income

-0.72x

Latest source

Provider fallback

Margin decomposition

Último año: revenue — · net income $976.7M · FCF $-703.5M

2022-FY → 2025-FY

Gross margin

—— pts

Operating margin

—— pts

Net margin

—— pts

FCF margin

—— pts
MetricTTM
2025
2024
2023
2022
Income Statement
Net Income$976.7M$976.7M$430.3M$1.31B—
EBITDA$-332.2M$-332.2M$1.04B$1.31B—
EPS——2.577.84—
Balance Sheet
Debt/Equity——0.01——
Current Ratio21.0921.09———
Cash Flow
Free Cash Flow$-703.5M$-703.5M$-471.5M$626.1M—
Returns
ROE10.8%10.8%5.3%18.8%—
Valuation
P/E11.7611.7616.39——
EV/EBITDA——6.77——
P/B1.231.230.87——
Growth & Yield
EPS Growth——-67.2%——

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +34.6%

Total return

+34.6%

Start / end P/E

n/dx → n/dx

EPS bridge

2.57 → n/d

Residual

+34.6%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+34.6%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.